Assenagon Asset Management S.A. lifted its holdings in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 15.9% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 29,819 shares of the company's stock after buying an additional 4,081 shares during the quarter. Assenagon Asset Management S.A. owned approximately 0.05% of Molina Healthcare worth $10,274,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also modified their holdings of the company. Innealta Capital LLC bought a new position in Molina Healthcare during the 2nd quarter worth $36,000. Ashton Thomas Private Wealth LLC acquired a new stake in shares of Molina Healthcare in the 2nd quarter worth about $40,000. AM Squared Ltd bought a new stake in Molina Healthcare in the 2nd quarter valued at about $59,000. UMB Bank n.a. boosted its stake in Molina Healthcare by 96.2% during the 3rd quarter. UMB Bank n.a. now owns 206 shares of the company's stock valued at $71,000 after purchasing an additional 101 shares during the period. Finally, Fidelis Capital Partners LLC acquired a new position in Molina Healthcare during the 1st quarter valued at about $151,000. 98.50% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on MOH shares. Deutsche Bank Aktiengesellschaft cut their price target on Molina Healthcare from $354.00 to $353.00 and set a "hold" rating on the stock in a report on Monday, July 29th. Barclays boosted their price target on Molina Healthcare from $359.00 to $372.00 and gave the stock an "equal weight" rating in a research report on Friday. Jefferies Financial Group lowered their price target on Molina Healthcare from $354.00 to $297.00 and set a "hold" rating on the stock in a report on Wednesday, July 24th. TD Cowen reduced their price objective on shares of Molina Healthcare from $412.00 to $351.00 and set a "buy" rating for the company in a report on Wednesday, July 24th. Finally, Stephens reissued an "equal weight" rating and set a $320.00 target price on shares of Molina Healthcare in a research note on Thursday, July 25th. One research analyst has rated the stock with a sell rating, six have given a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $367.00.
View Our Latest Analysis on MOH
Molina Healthcare Trading Down 3.2 %
Shares of MOH stock traded down $10.34 during trading hours on Monday, reaching $315.20. 767,123 shares of the stock traded hands, compared to its average volume of 527,230. The business has a fifty day moving average price of $335.23 and a 200 day moving average price of $329.39. Molina Healthcare, Inc. has a 1-year low of $272.69 and a 1-year high of $423.92. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $18.47 billion, a PE ratio of 17.10, a PEG ratio of 0.99 and a beta of 0.58.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, October 23rd. The company reported $6.01 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.96 by $0.05. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. The company had revenue of $10.34 billion during the quarter, compared to analyst estimates of $9.92 billion. During the same quarter in the prior year, the company earned $5.05 earnings per share. The company's revenue for the quarter was up 21.0% on a year-over-year basis. On average, equities research analysts forecast that Molina Healthcare, Inc. will post 23.5 EPS for the current year.
Insiders Place Their Bets
In related news, CAO Maurice Hebert sold 393 shares of the business's stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the transaction, the chief accounting officer now directly owns 9,473 shares of the company's stock, valued at approximately $3,282,583.96. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, CAO Maurice Hebert sold 393 shares of the stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total transaction of $136,182.36. Following the completion of the sale, the chief accounting officer now directly owns 9,473 shares in the company, valued at approximately $3,282,583.96. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total value of $339,210.00. Following the sale, the director now directly owns 18,025 shares of the company's stock, valued at approximately $6,114,260.25. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company's stock.
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.